Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
May 18, 2005
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 1,700 $4.83
May 18, 2005
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 300 $4.80
May 18, 2005
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 1,000 $4.69
May 18, 2005
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 500 $4.74
Mar 14, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Mar 14, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jan 03, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jan 03, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jan 03, 2005
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 --
Jan 03, 2005
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Jan 03, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jan 03, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jan 03, 2005
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 500,000 --
Jan 03, 2005
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Dec 13, 2004
Director
Director Initial Statement of Beneficial Ownership of Securities -- --
Dec 13, 2004
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jul 19, 2004
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 2,000 $5.11
Jul 16, 2004
Vice President Finance
Vice President Finance Open market or private purchase of non-derivative or derivative security 3,600 $5.10
Jul 10, 2004
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jul 10, 2004
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jul 10, 2004
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 --
Jul 10, 2004
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 --
Jul 10, 2004
President Oncology Division
President Oncology Division Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Jul 10, 2004
President Oncology Division
President Oncology Division Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 --
Jul 10, 2004
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.